The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[[(1R)-1-(carboxymethyl)-2-[4-(3-cyanophenyl)phenyl]ethyl]amino]-4-oxobutanoic acid ID: ALA4466321
PubChem CID: 49822299
Max Phase: Preclinical
Molecular Formula: C21H20N2O5
Molecular Weight: 380.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cccc(-c2ccc(C[C@H](CC(=O)O)NC(=O)CCC(=O)O)cc2)c1
Standard InChI: InChI=1S/C21H20N2O5/c22-13-15-2-1-3-17(10-15)16-6-4-14(5-7-16)11-18(12-21(27)28)23-19(24)8-9-20(25)26/h1-7,10,18H,8-9,11-12H2,(H,23,24)(H,25,26)(H,27,28)/t18-/m1/s1
Standard InChI Key: DONZXTXFCDZQJM-GOSISDBHSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
30.6694 -2.8148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4908 -2.8148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9016 -3.5289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7222 -3.5293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1316 -2.8169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7186 -2.1027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8994 -2.1058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9491 -2.8168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3622 -3.5297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1828 -3.5289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5912 -2.8160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1773 -2.1024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3581 -2.1066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2608 -3.5266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4395 -3.5266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6694 -4.2384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2608 -4.9503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6694 -5.6621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4395 -4.9503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.2608 -6.3739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6694 -7.0858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2608 -7.7935 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4908 -7.0858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0309 -2.8189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2137 -2.8189 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.4395 -2.1112 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.5837 -1.3966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9897 -0.6874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
5 8 1 0
14 1 1 1
14 15 1 0
14 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
15 24 1 0
24 25 2 0
24 26 1 0
27 28 3 0
12 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 380.40Molecular Weight (Monoisotopic): 380.1372AlogP: 2.59#Rotatable Bonds: 9Polar Surface Area: 127.49Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.86CX Basic pKa: ┄CX LogP: 2.31CX LogD: -3.72Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.61Np Likeness Score: -0.61
References 1. Kawanami T, Karki RG, Cody E, Liu Q, Liang G, Ksander GM, Rigel DF, Schiering N, Gong Y, Coppola GM, Iwaki Y, Sun R, Neubert A, Fan L, Ingles S, D'Arcy A, Villard F, Ramage P, Jeng AY, Leung-Chu J, Liu J, Beil M, Fu F, Chen W, Cumin F, Wiesmann C, Mogi M.. (2020) Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors., 11 (2): [PMID:32071687 ] [10.1021/acsmedchemlett.9b00578 ]